Clinical trial
An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer
NCT02515487 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer
- Lead sponsor
- NYU Langone Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- January 31, 2018
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer